021-51111890
购物车（）
sales@molnova.cn
GRGDSP
CAS No. 91037-75-1
GRGDSP ( ——— )
产品货号. M40592 CAS No. 91037-75-1
GRGDSP 是一种合成的线性RGD肽，是一种整联蛋白 (integrin) 抑制剂。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥1273 | 有现货 |
|
| 10MG | ￥2318 | 有现货 |
|
| 25MG | ￥5003 | 有现货 |
|
| 50MG | ￥7561 | 有现货 |
|
| 100MG | ￥10980 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称GRGDSP
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述GRGDSP 是一种合成的线性RGD肽，是一种整联蛋白 (integrin) 抑制剂。
-
产品描述GRGDSP, a synthetic linear RGD peptide, is an integrin inhibitor.
-
体外实验———
-
体内实验It is demonstrated that transarterial infusion of GRGDSP (Gly-Arg-Gly-Asp-Ser-Pro integrin-inhibitor which includes RGD-peptide). As a synthetic linear RGD peptide, GRGDSP (Gly-Arg-Gly-Asp-Ser-Pro) can inhibit the adherence of tumor cells to endothelial cells of blood vessels and limit its metastasis. GRGDSP (Gly-Arg-Gly-Asp-Ser-Pro) is used as a soluble integrin-blocking RGD-based peptide. GRGDSP is used widely together with other RGD peptides in integrin research. GRGDSP can be used to modify the surface of cardiovascular implants such as vascular grafts to promote endothelialization.
-
同义词———
-
通路Others
-
靶点Other Targets
-
受体Integrin
-
研究领域———
-
适应症———
化学信息
-
CAS Number91037-75-1
-
分子量587.58
-
分子式C22H37N9O10
-
纯度>98% (HPLC)
-
溶解度H2O : 100 mg/mL (170.19 mM; ultraphonic)
-
SMILES———
-
化学全称———
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Qian J, et al. Transarterial administration of integrin inhibitor loaded nanoparticles combined with transarterial chemoembolization for treating hepatocellular carcinoma in a rat model. World J Gastroenterol. 2016 Jun 7;22(21):5042-9.?
产品手册
关联产品
-
NLS PKKKRKV
NLS (PKKKRKV) is a peptide derived from the 40 tumor antigen of the great ape virus (SV40 big T antigen), which is a method to enhance the nuclear portal in the research field of gene transfer.
-
ND-011992
ND-011992 是一种可逆的选择性喹唑啉类抑制剂，靶向醌还原酶 (quinone reductases) 和醌氧化酶 (quinol oxidases)。ND-011992 抑制大肠杆菌 BL21*Δcyo 呼吸复合体I (respiratory complex I) 和 bo3 氧化酶(bo3 oxidase)，以及 bd-I 氧化酶 (bd-I oxidases) 和 bd-II 氧化酶 (bd-II oxidases)，IC50 分别为 0.12、2.47、0.63 和 1.3 μM。ND-011992 可以用于肺结核的研究。
-
Licoricone
Licoricone exhibits anti-helicobacter pylori activity against the CLAR and AMOX-resistant strain as well as four CLAR (AMOX)-sensitive strains.
